Visioneering Technologies, Inc. (VTI:ASX)

3.1¢

right-arrow Created with Sketch. 0 (0%)
MCAP $30.80M
Last trade 15.50pm 01/12/2020 20mins delayed

Latest Announcements

26/11/2020VTIVisioneering Technologies, Inc.
23/11/2020VTIVisioneering Technologies, Inc.
16/11/2020VTIVisioneering Technologies, Inc.
11/11/2020VTIVisioneering Technologies, Inc.
11/11/2020VTIVisioneering Technologies, Inc.
06/11/2020VTIVisioneering Technologies, Inc.
06/11/2020VTIVisioneering Technologies, Inc.
06/11/2020VTIVisioneering Technologies, Inc.

Company Overview

Visioneering Technologies, Inc. is a medical device company. The Company's principal activity is the design, manufacture, sale and distribution of its NaturalVue Multifocal 1 Day (NaturalVue MF) contact lenses for adults with Presbyopia (an age-related condition resulting in difficulty seeing near objects) and children with Myopia (difficulty seeing distant objects). The Company offers NaturalVue MF contact lens. Its Multifocal contact lens provides Presbyopia patients with near, intermediate and distance vision and which is much easier for eye care professionals to fit to their patients. The Company's NaturalVue MF contact lenses are also used by eye care professionals for Myopia correction in children. The Company has a range of line extensions and products, such as NaturalVue Multifocal 1 Day contact lens power range extension; NaturalVue Sphere 1 Day contact lenses; NaturalVue Toric 1 Day contact lenses, and NaturalVue Multifocal Toric 1 Day contact lenses.

VTI in the news

Search Previous Announcements